Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Prostate Cancer

  Free Subscription


Articles published in Mod Pathol

Retrieve available abstracts of 16 articles:
HTML format
Text format



Single Articles


    June 2019
  1. MIYAI K, Mikoshi A, Hamabe F, Nakanishi K, et al
    Histological differences in cancer cells, stroma, and luminal spaces strongly correlate with in vivo MRI-detectability of prostate cancer.
    Mod Pathol. 2019 Jun 7. pii: 10.1038/s41379-019-0292.
    PubMed     Text format     Abstract available


    April 2019
  2. HAMMARSTEN P, Josefsson A, Thysell E, Lundholm M, et al
    Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome.
    Mod Pathol. 2019 Apr 12. pii: 10.1038/s41379-019-0260.
    PubMed     Text format     Abstract available


  3. KAMMERER-JACQUET SF, Ahmad A, Moller H, Sandu H, et al
    Ki-67 is an independent predictor of prostate cancer death in routine needle biopsy samples: proving utility for routine assessments.
    Mod Pathol. 2019 Apr 11. pii: 10.1038/s41379-019-0268.
    PubMed     Text format     Abstract available


    February 2019
  4. VERHOEF EI, van Cappellen WA, Slotman JA, Kremers GJ, et al
    Three-dimensional analysis reveals two major architectural subgroups of prostate cancer growth patterns.
    Mod Pathol. 2019 Feb 8. pii: 10.1038/s41379-019-0221.
    PubMed     Text format     Abstract available


    October 2018
  5. HOLLEMANS E, Verhoef EI, Bangma CH, Rietbergen J, et al
    Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis.
    Mod Pathol. 2018 Oct 22. pii: 10.1038/s41379-018-0157.
    PubMed     Text format     Abstract available


    August 2018
  6. BRAMHECHA YM, Rouzbeh S, Guerard KP, Scarlata E, et al
    The combination of PTEN deletion and 16p13.3 gain in prostate cancer provides additional prognostic information in patients treated with radical prostatectomy.
    Mod Pathol. 2018 Aug 23. pii: 10.1038/s41379-018-0107.
    PubMed     Text format     Abstract available


    May 2018
  7. KAUR HB, Guedes LB, Lu J, Maldonado L, et al
    Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer.
    Mod Pathol. 2018 May 30. pii: 10.1038/s41379-018-0083.
    PubMed     Text format     Abstract available


    March 2018
  8. TANG Z, Zhang J, Chen H, Lu S, et al
    Reply to Lambros et al.
    Mod Pathol. 2018;31:541-542.
    PubMed     Text format    


    January 2018
  9. GRIGNON DJ
    Prostate cancer reporting and staging: needle biopsy and radical prostatectomy specimens.
    Mod Pathol. 2018;31.
    PubMed     Text format     Abstract available


  10. EVANS AJ
    Treatment effects in prostate cancer.
    Mod Pathol. 2018;31.
    PubMed     Text format     Abstract available


  11. RUBIN MA, Demichelis F
    The Genomics of Prostate Cancer: emerging understanding with technologic advances.
    Mod Pathol. 2018;31.
    PubMed     Text format     Abstract available


  12. KRISTIANSEN G
    Markers of clinical utility in the differential diagnosis and prognosis of prostate cancer.
    Mod Pathol. 2018;31.
    PubMed     Text format     Abstract available


  13. MAGI-GALLUZZI C
    Prostate cancer: diagnostic criteria and role of immunohistochemistry.
    Mod Pathol. 2018;31.
    PubMed     Text format     Abstract available


  14. EPSTEIN JI
    Prostate cancer grading: a decade after the 2005 modified system.
    Mod Pathol. 2018;31.
    PubMed     Text format     Abstract available


    October 2017
  15. LI H, Wang Z, Xiao W, Yan L, et al
    Androgen-receptor splice variant-7-positive prostate cancer: a novel molecular subtype with markedly worse androgen-deprivation therapy outcomes in newly diagnosed patients.
    Mod Pathol. 2017 Oct 27. doi: 10.1038/modpathol.2017.
    PubMed     Text format     Abstract available


    May 2017
  16. KWELDAM CF, Kummerlin IP, Nieboer D, Steyerberg EW, et al
    Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer.
    Mod Pathol. 2017 May 19. doi: 10.1038/modpathol.2017.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: